SCHEMBL595457

SCHEMBL595457

CCC=C(CC12CC3CC(CC(C3)C1)C2)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 1/20 0.44
HSD11B1 P28845 1/20 0.43
GRIK1 P39086 1/20 0.42
GRIK2 Q13002 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
EPHX2 P34913 1/20 0.42
BPTF Q12830 1/20 0.41
P2RX7 Q99572 1/20 0.41
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6125488 1.00 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2HSD11B1GRIK1GRIK2
SCHEMBL3207196 0.84 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2HSD11B1NPSR1EPHX2
SCHEMBL596453 0.84 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2HSD11B1NPSR1EPHX2
SCHEMBL906382 0.80 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2HSD11B1NPSR1BPTF
SCHEMBL3215937 0.78 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2HSD11B1GRIK1GRIK2
SCHEMBL6125490 0.76 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2HSD11B1NPSR1EPHX2
SCHEMBL4104059 0.73 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2HSD11B1NPSR1EPHX2
SCHEMBL5669515 0.72 GAA (0.49) ALDH1A1MEN1KMT2A
SCHEMBL7523671 0.71 HSD11B1 (0.40) ALDH1A1HSD11B1MEN1KMT2A
SCHEMBL14687892 0.71 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2NPSR1EPHX2BPTF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115036-B2 Fluorine-containing cyclic compound, fluorine-containing polymer compound, resist material using same and method for forming pattern CENTRAL GLASS COMPANY, LIMITED (JP) 2012-02-14 US disclosed
US-20100204422-A1 Fluorine-Containing Cyclic Compound, Fluorine-Containing Polymer Compound, Resist Material Using Same and Method for Forming Pattern CENTRAL GLASS COMPANY, LIMITED (JP) 2010-08-12 US disclosed
US-7736835-B2 Fluorine-containing cyclic compound, fluorine-containing polymer compound, resist material using same and method for forming pattern CENTRAL GLASS COMPANY, LIMITED (JP) 2010-06-15 US disclosed
WO-2009019574-A1 PHOTORESIST COMPOSITION FOR DEEP UV AND PROCESS THEREOF AZ ELECTRONIC MATERIALS USA CORP. (DE) 2009-02-12 WO disclosed
US-20090042148-A1 Photoresist Composition for Deep UV and Process Thereof AZ ELECTRONIC MATERIALS USA CORP. 2009-02-12 US disclosed
US-20080003517-A1 Fluorine-Containing Cyclic Compound, Fluorine-Containing Polymer Compound, Resist Material Using Same and Method for Forming Pattern CENTRAL GLASS COMPANY, LIMITED (JP) 2008-01-03 US disclosed
WO-2002021212-A2 FLUORINATED PHENOLIC POLYMERS AND PHOTORESIST COMPOSITIONS COMPRISING SAME SHIPLEY COMPANY, L.L.C. (US) 2002-03-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204422-A1 Fluorine-Containing Cyclic Compound, Fluorine-Containing Polymer Compound, Resist Material Using Same and Method for Forming Pattern AFF1, AFF2, FGFR1 ALDH1A1 903/4885SMN1; SMN2 1646/4885HSD11B1 2242/4885
US-20080003517-A1 Fluorine-Containing Cyclic Compound, Fluorine-Containing Polymer Compound, Resist Material Using Same and Method for Forming Pattern AFF1, AFF2, FGFR1 ALDH1A1 903/4885SMN1; SMN2 1646/4885HSD11B1 2242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.